NFKB1 and osteoarthritis: In a rat osteoarthritis model miR-326 delivered by BMSC-Exos, which targets HDAC3 and STAT1//NF-κB p65, can inhibit cartilage atrophy, thereby ameliorating osteoarthritis (Xu and Xu, 2021).